Robyn Leary's Colleagues at QED Therapeutics
Robyn Leary's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Robyn Leary's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Robyn Leary
Robyn Leary currently works for QED Therapeutics.
Robyn Leary's role at QED Therapeutics is associate director scientific communications.
Robyn Leary's email address is ***@qedtx.com. To view Robyn Leary's full email address, please signup to ConnectPlex.
Robyn Leary works in the Biotechnology industry.
Robyn Leary's colleagues at QED Therapeutics are Greg Troupe, Terry Cho, Hiywot MS, Devendra A., Timothy Bisson, Quinn Nazarewycz, Jennifer Lai and others.
Robyn Leary's phone number is ["+16307294554"]